Peter E. Grebow

This profile gathers the share dealings of Peter E. Grebow across 2 companies, led by Cephalon Inc and Optimer Pharmaceuticals Inc. Over a trading history stretching from 17 February 2006 to 24 October 2013, the count stands at 133 filings.

The open-market record consists of 92 sales worth €11.1M, with no purchase. Besides market trades, the filings include 29 share grants and 9 option exercises.

The latest filing, published on 28 October 2013, reports a transaction of €58k in Optimer Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.